Skip to main content
13 August 2026
30 January 2025

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda announced that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Mr. Weber retires from the company in June 2026.…

28 January 2025

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, announced the Board of Directors has appointed Adam Sayer as President and Chief Executive Officer effective immediately. He will also serve on the company’s Board of Directors. Sayer was most recently Chief Transfo…

Page 14 of 14